Your session is about to expire
← Back to Search
Eyes with abnormal anterior segment for Cataract
N/A
Recruiting
Led By Jeffrey Fischer, MD
Research Sponsored by Heidelberg Engineering GmbH
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 day
Awards & highlights
Summary
This study is conducted to compare the the investigational device ANTERION with software version 1.5 against the ANTERION with software version 1.2.4 (cleared version)
Eligible Conditions
- Cataract
- Healthy Eyes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Anterior Chamber Depth
Axial Length
Central Cornea Thickness
+2 moreSecondary outcome measures
Adverse Events Rate
Trial Design
2Treatment groups
Experimental Treatment
Group I: Eyes with normal anterior segmentExperimental Treatment1 Intervention
Group II: Eyes with abnormal anterior segmentExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Heidelberg Engineering GmbHLead Sponsor
18 Previous Clinical Trials
2,239 Total Patients Enrolled
1 Trials studying Cataract
176 Patients Enrolled for Cataract
Jeffrey Fischer, MDPrincipal InvestigatorFischer Laser Eye Center
Share this study with friends
Copy Link
Messenger